Scotia Capital Lowered Cme Group (CME) Stake; Kennedy Capital Management Raised Its …

Scotia Capital Inc decreased Cme Group Inc (CME) stake by 91.39% reported in 2019Q1 SEC filing. Scotia Capital Inc sold 16,964 shares as Cme …

Ardmore Shipping Corporation (NYSE:ASC) Logo

Scotia Capital Inc decreased Cme Group Inc (CME) stake by 91.39% reported in 2019Q1 SEC filing. Scotia Capital Inc sold 16,964 shares as Cme Group Inc (CME)’s stock rose 10.91%. The Scotia Capital Inc holds 1,599 shares with $263,000 value, down from 18,563 last quarter. Cme Group Inc now has $78.19 billion valuation. The stock increased 1.06% or $2.21 during the last trading session, reaching $211.1. About 814,721 shares traded. CME Group Inc. (NASDAQ:CME) has risen 21.77% since August 8, 2018 and is uptrending. It has outperformed by 21.77% the S&P500. Some Historical CME News: 16/03/2018 – CME Group Statement Regarding Potential Offer for NEX Group; 29/03/2018 – CME Group To Acquire NEX Group Plc, Bringing Together Cash, Futures And OTC Marketplaces; 02/05/2018 – CME: BARCLAYS PLC: Form 8.5 (EPT/NON-RI) – CME GROUP PLC AMENDMENT; 22/04/2018 – DJ CME Group Inc Class A, Inst Holders, 1Q 2018 (CME); 16/03/2018 – RPT-CME GROUP INC. – STATEMENT RE POSSIBLE OFFER; 06/05/2018 – Judge cancels planned CME hearing; 15/05/2018 – CME lumber futures final vol/open int for May 14; 02/04/2018 – CME March volume up 12.3 percent to 437.3 mln contracts; 02/04/2018 – CME lumber futures final vol/open int for March 29; 11/05/2018 – LIVESTOCK-CME hog futures slump amid fund roll, NAFTA worries

Kennedy Capital Management Inc increased Ardmore Shipping Corp (ASC) stake by 125.32% reported in 2019Q1 SEC filing. Kennedy Capital Management Inc acquired 125,317 shares as Ardmore Shipping Corp (ASC)’s stock declined 0.14%. The Kennedy Capital Management Inc holds 225,317 shares with $1.39 million value, up from 100,000 last quarter. Ardmore Shipping Corp now has $210.50 million valuation. The stock decreased 0.16% or $0.01 during the last trading session, reaching $6.36. About 243,690 shares traded or 10.76% up from the average. Ardmore Shipping Corporation (NYSE:ASC) has risen 5.61% since August 8, 2018 and is uptrending. It has outperformed by 5.61% the S&P500. Some Historical ASC News: 11/04/2018 – Ardmore Shipping Closes Above 200-Day Moving Average; 30/03/2018 – Fed KC: U.S. and Ardmore Area Economic Update – March 29, 2018; 09/05/2018 – Ardmore Shipping Forms Golden Cross: Technicals; 19/04/2018 – Ardmore Shipping Presenting at Conference Tomorrow; 17/05/2018 – CENTREX METALS – SIGNED NON-BINDING MOU WITH GUJARAT STATE FERTILISERS & CHEMICALS FOR SUPPLY OF PRODUCT FROM ARDMORE PHOSPHATE ROCK PROJECT; 29/03/2018 – Ardmore Shipping Presenting at Conference Apr 24; 09/04/2018 – Lisa Vanderpump to Sign Bottles of Signature Rosé at Fine Wine & Good Spirits Premium Collection Store in Ardmore, Montgomery County; 02/05/2018 – Ardmore Shipping Corporation Announces Financial Results For The Three Months Ended March 31, 2018; 06/04/2018 – S&PGR Rates Irish RMBS Deal Ardmore Securities No. 1; 27/03/2018 – Ardmore Shipping Presenting at Conference Apr 20

Scotia Capital Inc increased Ishares Tr (FLOT) stake by 74,669 shares to 226,104 valued at $11.51M in 2019Q1. It also upped Prologis Inc (NYSE:PLD) stake by 30,497 shares and now owns 100,005 shares. Dollar Gen Corp New (NYSE:DG) was raised too.

Investors sentiment decreased to 1 in Q1 2019. Its down 0.19, from 1.19 in 2018Q4. It dropped, as 53 investors sold CME shares while 265 reduced holdings. 90 funds opened positions while 228 raised stakes. 282.94 million shares or 5.14% less from 298.28 million shares in 2018Q4 were reported. Pathstone Family Office Lc holds 206 shares or 0% of its portfolio. Moreover, Tower Rech Capital Ltd Com (Trc) has 0.07% invested in CME Group Inc. (NASDAQ:CME). Wesbanco Bank owns 2,147 shares. Gideon Capital Advisors Incorporated holds 12,709 shares or 0.75% of its portfolio. Walleye Trading Llc has 11,276 shares for 0.01% of their portfolio. Dnb Asset As holds 0% of its portfolio in CME Group Inc. (NASDAQ:CME) for 41,057 shares. First Interstate National Bank holds 0% or 27 shares in its portfolio. Cornerstone reported 2,076 shares. Smith Asset Management Group LP reported 60 shares or 0% of all its holdings. Sit Associate holds 0.23% in CME Group Inc. (NASDAQ:CME) or 43,910 shares. Twin Capital Management invested in 0.15% or 18,760 shares. Keybank National Association Oh reported 254,942 shares. Forte Capital Limited Com Adv accumulated 26,041 shares or 1.54% of the stock. Guinness Atkinson Asset Mngmt accumulated 1,520 shares or 0.19% of the stock. The Saskatchewan – Canada-based Greystone Managed Investments has invested 0.17% in CME Group Inc. (NASDAQ:CME).

More notable recent CME Group Inc. (NASDAQ:CME) news were published by: Nasdaq.com which released: “Gemini Exchange Data Is Being Added to CME’s Crypto Indices – Nasdaq” on August 08, 2019, also Nasdaq.com with their article: “CME Group (CME) Q2 Earnings Top Estimates, Revenues Miss – Nasdaq” published on July 31, 2019, Nasdaq.com published: “What’s in Store for CME Group (CME) This Earnings Season? – Nasdaq” on July 26, 2019. More interesting news about CME Group Inc. (NASDAQ:CME) were released by: Nasdaq.com and their article: “CME September 6th Options Begin Trading – Nasdaq” published on July 29, 2019 as well as Nasdaq.com‘s news article titled: “XLF, BRK.B, CME, CB: ETF Inflow Alert – Nasdaq” with publication date: August 01, 2019.

Among 8 analysts covering CME Group (NASDAQ:CME), 4 have Buy rating, 2 Sell and 2 Hold. Therefore 50% are positive. CME Group had 17 analyst reports since February 15, 2019 according to SRatingsIntel. The firm earned “Buy” rating on Friday, March 15 by Deutsche Bank. Barclays Capital maintained the shares of CME in report on Tuesday, March 26 with “Overweight” rating. On Wednesday, July 3 the stock rating was maintained by UBS with “Neutral”. The rating was maintained by Wells Fargo with “Market Perform” on Wednesday, July 3. JP Morgan downgraded the shares of CME in report on Friday, February 15 to “Underweight” rating. The stock has “Sell” rating by J.P. Morgan on Friday, March 22. The firm earned “Neutral” rating on Wednesday, June 5 by UBS. The firm earned “Buy” rating on Friday, February 15 by Bernstein. UBS maintained it with “Neutral” rating and $17500 target in Thursday, May 2 report.

CME Group Inc. (NASDAQ:CME) Institutional Positions Chart

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.

Related Posts:

  • No Related Posts

CME Group Inc (NASDAQ:CME) Shares Purchased by Fulcrum Capital LLC

Fulcrum Capital LLC increased its stake in CME Group Inc (NASDAQ:CME) by 0.4% in the second quarter, according to the company in its most recent …

CME Group logoFulcrum Capital LLC increased its stake in CME Group Inc (NASDAQ:CME) by 0.4% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 38,975 shares of the financial services provider’s stock after purchasing an additional 146 shares during the period. CME Group makes up 2.8% of Fulcrum Capital LLC’s holdings, making the stock its 9th largest position. Fulcrum Capital LLC’s holdings in CME Group were worth $7,565,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Truvestments Capital LLC purchased a new position in CME Group in the 1st quarter worth approximately $32,000. Close Asset Management Ltd acquired a new stake in CME Group during the first quarter valued at approximately $34,000. Westside Investment Management Inc. acquired a new stake in CME Group during the second quarter valued at approximately $38,000. Permanens Capital L.P. acquired a new stake in CME Group during the first quarter valued at approximately $41,000. Finally, Berman Capital Advisors LLC raised its stake in CME Group by 23.9% during the first quarter. Berman Capital Advisors LLC now owns 342 shares of the financial services provider’s stock valued at $56,000 after buying an additional 66 shares in the last quarter. 84.58% of the stock is owned by hedge funds and other institutional investors.

In other CME Group news, insider Kathleen M. Cronin sold 4,960 shares of the business’s stock in a transaction that occurred on Tuesday, May 21st. The shares were sold at an average price of $186.69, for a total value of $925,982.40. Following the completion of the transaction, the insider now owns 49,337 shares of the company’s stock, valued at approximately $9,210,724.53. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Timothy S. Bitsberger sold 700 shares of the business’s stock in a transaction that occurred on Tuesday, June 4th. The stock was sold at an average price of $194.35, for a total transaction of $136,045.00. Following the completion of the transaction, the director now directly owns 9,421 shares of the company’s stock, valued at approximately $1,830,971.35. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 78,873 shares of company stock worth $15,707,799. Company insiders own 1.20% of the company’s stock.

CME has been the topic of a number of research reports. Wells Fargo & Co increased their price target on CME Group from $176.00 to $200.00 and gave the stock a “market perform” rating in a research report on Wednesday, July 3rd. Barclays increased their price target on CME Group from $191.00 to $197.00 and gave the company an “overweight” rating in a research note on Thursday, May 23rd. Rosenblatt Securities lowered CME Group from a “neutral” rating to a “sell” rating in a research note on Thursday, April 18th. Zacks Investment Research lowered CME Group from a “hold” rating to a “sell” rating and set a $158.00 price objective for the company. in a research note on Monday, May 27th. Finally, Citigroup set a $202.00 price objective on CME Group and gave the stock a “buy” rating in a research note on Thursday, May 2nd. Three investment analysts have rated the stock with a sell rating, five have assigned a hold rating and eight have issued a buy rating to the stock. CME Group has an average rating of “Hold” and a consensus target price of $192.14.

Shares of NASDAQ:CME opened at $208.89 on Thursday. The stock’s 50 day simple moving average is $201.54. CME Group Inc has a 12-month low of $161.05 and a 12-month high of $210.17. The firm has a market cap of $72.07 billion, a price-to-earnings ratio of 30.63, a PEG ratio of 4.51 and a beta of 0.23. The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.04 and a current ratio of 1.05.

CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, July 31st. The financial services provider reported $1.76 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.75 by $0.01. CME Group had a net margin of 39.36% and a return on equity of 9.14%. The firm had revenue of $1.27 billion for the quarter, compared to analyst estimates of $1.27 billion. During the same quarter in the prior year, the business posted $1.74 EPS. The business’s revenue was up 20.1% compared to the same quarter last year. Analysts forecast that CME Group Inc will post 6.66 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 25th. Shareholders of record on Tuesday, September 10th will be given a dividend of $0.75 per share. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.44%. CME Group’s payout ratio is presently 43.99%.

CME Group Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Further Reading: What is the Difference Between Common Shares and Convertible Shares?

Want to see what other hedge funds are holding CME?Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for CME Group and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

Cme Group (CME) Stock Price Rose While Cantillon Capital Management Has Lowered Position …

Cantillon Capital Management Llc decreased its stake in Cme Group Inc (CME) by 0.48% based on its latest 2019Q1 regulatory filing with the SEC.

Inphi Corporation (NYSE:IPHI) Logo

Cantillon Capital Management Llc decreased its stake in Cme Group Inc (CME) by 0.48% based on its latest 2019Q1 regulatory filing with the SEC. Cantillon Capital Management Llc sold 9,358 shares as the company’s stock rose 10.91% . The hedge fund held 1.93M shares of the investment bankers and brokers and service company at the end of 2019Q1, valued at $317.11 million, down from 1.94 million at the end of the previous reported quarter. Cantillon Capital Management Llc who had been investing in Cme Group Inc for a number of months, seems to be less bullish one the $77.74B market cap company. The stock increased 0.48% or $1 during the last trading session, reaching $209.89. About 469,684 shares traded. CME Group Inc. (NASDAQ:CME) has risen 21.77% since August 8, 2018 and is uptrending. It has outperformed by 21.77% the S&P500. Some Historical CME News: 06/04/2018 – CME LIVE CATTLE FUTURES 0#LC: SAG MORE THAN 1 PERCENT PRESSURED BY PROFIT-TAKING, RENEWED TRADE WAR WORRIES -TRADE; 18/04/2018 – CME LEAN HOG FUTURES 0#LH: SURGE MORE THAN 2 PERCENT ON FUND BUYING, HIGHER CASH AND WHOLESALE PORK PRICES -TRADE; 19/03/2018 – Intercontinental Exchange Announces Transition of Credit Default Swap Open Interest from CME Group to ICE Clear Credit; Launche; 04/04/2018 – CME Group and GCSA Capital Collaborate to Deliver the Prefunded Treasury Facility Collateral Program for Meeting Performance Bo; 28/03/2018 – CME lumber futures final vol/open int for March 27; 27/03/2018 – REG-BARCLAYS PLC FORM 8.5 (EPT/NON-Rl) – CME GROUP PLC; 04/04/2018 – CME FEEDER CATTLE BACK MONTHS 0#FC: FALL OVER 1 PCT ON LOWER LIVE CATTLE FUTURES, WORRIES OVER CHINA’S TARIFF HIKE ON U.S. BEEF -TRADE; 20/03/2018 – CME lumber futures final vol/open int for March 19; 21/05/2018 – CME variable storage rate data for CBOT wheat; 28/03/2018 – CME, NEX SAID TO PLAN ANNOUNCING DEAL IN COMING DAYS

Elk Creek Partners Llc decreased its stake in Inphi Corp (IPHI) by 22.28% based on its latest 2019Q1 regulatory filing with the SEC. Elk Creek Partners Llc sold 163,422 shares as the company’s stock rose 25.94% . The institutional investor held 570,017 shares of the semiconductors company at the end of 2019Q1, valued at $24.93 million, down from 733,439 at the end of the previous reported quarter. Elk Creek Partners Llc who had been investing in Inphi Corp for a number of months, seems to be less bullish one the $2.98 billion market cap company. The stock increased 2.78% or $1.78 during the last trading session, reaching $65.83. About 812,602 shares traded. Inphi Corporation (NYSE:IPHI) has risen 88.51% since August 8, 2018 and is uptrending. It has outperformed by 88.51% the S&P500. Some Historical IPHI News: 22/03/2018 – Inphi 16nm Polaris PAM4 Platform Named Winner in 2018 Lightwave Innovation Reviews Program; 08/03/2018 – Inphi Opens OFC 2018 with Comprehensive Portfolio of Solutions for Data Center Interconnects and Inside Data Centers; 24/04/2018 – Inphi 1Q Loss $23M; 24/04/2018 – INPHI 1Q REV. CONT OPS $60.1M, EST. $59.8M; 24/04/2018 – Inphi Sees 2Q Adj EPS 12c-Adj EPS 14c; 24/04/2018 – Inphi Sees 2Q Rev $67.3M-$71.3M; 24/04/2018 – Inphi 1Q Loss/Shr 53c; 15/05/2018 – Zevenbergen Capital Inv LLC Exits Position in Inphi; 20/03/2018 – lnphi and lnnovium Announce Multiple Industry-leading 100G-400G Data Center Solutions; 08/03/2018 lnphi Opens OFC 2018 with Comprehensive Portfolio of Solutions for Data Center lnterconnects and Inside Data Centers

Since February 8, 2019, it had 0 buys, and 2 insider sales for $1.88 million activity. Tamer Ford also sold $1.48M worth of Inphi Corporation (NYSE:IPHI) on Tuesday, February 12. On Tuesday, February 12 EDMUNDS JOHN sold $400,000 worth of Inphi Corporation (NYSE:IPHI) or 10,000 shares.

Investors sentiment increased to 1.4 in Q1 2019. Its up 0.28, from 1.12 in 2018Q4. It is positive, as 16 investors sold IPHI shares while 46 reduced holdings. 38 funds opened positions while 49 raised stakes. 77.68 million shares or 60.55% more from 48.38 million shares in 2018Q4 were reported. Alliancebernstein LP has 0% invested in Inphi Corporation (NYSE:IPHI). Td Asset owns 0% invested in Inphi Corporation (NYSE:IPHI) for 37,805 shares. Invesco Ltd owns 132,609 shares. California-based Cap Glob Invsts has invested 0.05% in Inphi Corporation (NYSE:IPHI). Northern Tru Corp reported 566,742 shares. Juncture Wealth Strategies Llc has 12,346 shares. Grandeur Peak Global Advisors Limited Com reported 212,075 shares. Metropolitan Life Insurance Co holds 14,098 shares. 35,362 are owned by Segall Bryant & Hamill Ltd Liability Company. Svcs Automobile Association holds 0.01% in Inphi Corporation (NYSE:IPHI) or 67,851 shares. Granahan Management Ma holds 68,612 shares. Rothschild Inv Il accumulated 17,200 shares. National Bank Of America Corporation De has 249,432 shares for 0% of their portfolio. State Board Of Administration Of Florida Retirement invested in 18,927 shares or 0% of the stock. Marshall Wace Limited Liability Partnership holds 1,599 shares or 0% of its portfolio.

More notable recent Inphi Corporation (NYSE:IPHI) news were published by: Benzinga.com which released: “22 Stocks Moving In Monday’s Pre-Market Session – Benzinga” on July 01, 2019, also Globenewswire.com with their article: “Inphi Corporation Announces Q4 and FY 2017 Results – GlobeNewswire” published on February 07, 2018, Seekingalpha.com published: “NPTN could benefit from ACIA’s acquisition – analysts – Seeking Alpha” on July 10, 2019. More interesting news about Inphi Corporation (NYSE:IPHI) were released by: Globenewswire.com and their article: “Inphi Unveils Latest Portfolio Solutions for Data Center Interconnects at OFC 2019 – GlobeNewswire” published on February 26, 2019 as well as Finance.Yahoo.com‘s news article titled: “Should You Investigate Inphi Corporation (NYSE:IPHI) At US$45.80? – Yahoo Finance” with publication date: June 11, 2019.

Elk Creek Partners Llc, which manages about $800.79 million and $1.39B US Long portfolio, upped its stake in Teladoc Health Inc by 37,882 shares to 165,016 shares, valued at $9.18M in 2019Q1, according to the filing. It also increased its holding in Stericycle Inc (NASDAQ:SRCL) by 7,013 shares in the quarter, for a total of 52,202 shares, and has risen its stake in Playa Hotels & Resorts Nv.

More notable recent CME Group Inc. (NASDAQ:CME) news were published by: Nasdaq.com which released: “U.S. employment growth seen slowing in July; wage gains steady – Nasdaq” on August 02, 2019, also Nasdaq.com with their article: “CME’s second-quarter earnings fall, expenses weigh – Nasdaq” published on July 31, 2019, Nasdaq.com published: “TD Ameritrade Holding Corporation (AMTD) Ex-Dividend Date Scheduled for August 05, 2019 – Nasdaq” on August 02, 2019. More interesting news about CME Group Inc. (NASDAQ:CME) were released by: Nasdaq.com and their article: “Oppenheimer Holdings, Inc. (OPY) Ex-Dividend Date Scheduled for August 08, 2019 – Nasdaq” published on August 07, 2019 as well as Nasdaq.com‘s news article titled: “CME Group Breaks Above 200-Day Moving Average – Bullish for CME – Nasdaq” with publication date: April 17, 2019.

Inphi Corporation (NYSE:IPHI) Institutional Positions Chart

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.

Related Posts:

  • No Related Posts

Creative Planning Has $4.87 Million Holdings in CME Group Inc (NASDAQ:CME)

Creative Planning cut its position in CME Group Inc (NASDAQ:CME) by 4.8% during the second quarter, according to the company in its most recent …

CME Group logoCreative Planning cut its position in CME Group Inc (NASDAQ:CME) by 4.8% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 25,070 shares of the financial services provider’s stock after selling 1,271 shares during the period. Creative Planning’s holdings in CME Group were worth $4,866,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Steward Partners Investment Advisory LLC raised its stake in shares of CME Group by 11.6% during the second quarter. Steward Partners Investment Advisory LLC now owns 36,315 shares of the financial services provider’s stock worth $7,049,000 after buying an additional 3,789 shares during the last quarter. Swarthmore Group Inc. raised its stake in shares of CME Group by 930.6% during the second quarter. Swarthmore Group Inc. now owns 37,100 shares of the financial services provider’s stock worth $7,201,000 after buying an additional 33,500 shares during the last quarter. Shine Investment Advisory Services Inc. raised its stake in shares of CME Group by 41.1% during the second quarter. Shine Investment Advisory Services Inc. now owns 625 shares of the financial services provider’s stock worth $121,000 after buying an additional 182 shares during the last quarter. Doliver Advisors LP raised its stake in shares of CME Group by 18.9% during the second quarter. Doliver Advisors LP now owns 4,400 shares of the financial services provider’s stock worth $854,000 after buying an additional 698 shares during the last quarter. Finally, Ballentine Partners LLC bought a new stake in shares of CME Group during the second quarter worth approximately $313,000. 84.58% of the stock is owned by institutional investors.

A number of research firms recently weighed in on CME. BidaskClub downgraded shares of CME Group from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, June 11th. Wells Fargo & Co boosted their price target on shares of CME Group from $176.00 to $200.00 and gave the stock a “market perform” rating in a research note on Wednesday, July 3rd. Zacks Investment Research downgraded shares of CME Group from a “hold” rating to a “sell” rating and set a $158.00 price target for the company. in a research note on Monday, May 27th. Rosenblatt Securities downgraded shares of CME Group from a “neutral” rating to a “sell” rating in a research note on Thursday, April 18th. Finally, ValuEngine raised shares of CME Group from a “hold” rating to a “buy” rating in a research note on Wednesday, May 8th. Three equities research analysts have rated the stock with a sell rating, five have given a hold rating and eight have assigned a buy rating to the stock. The stock currently has a consensus rating of “Hold” and an average price target of $192.14.

In other news, Director Howard J. Siegel sold 5,000 shares of the company’s stock in a transaction that occurred on Friday, August 2nd. The shares were sold at an average price of $205.00, for a total value of $1,025,000.00. Following the completion of the transaction, the director now owns 80,382 shares in the company, valued at $16,478,310. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Terrence A. Duffy sold 35,000 shares of the company’s stock in a transaction that occurred on Thursday, August 1st. The shares were sold at an average price of $200.15, for a total transaction of $7,005,250.00. Following the completion of the transaction, the chief executive officer now owns 79,057 shares of the company’s stock, valued at approximately $15,823,258.55. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 78,873 shares of company stock valued at $15,707,799. Corporate insiders own 1.20% of the company’s stock.

Shares of NASDAQ CME opened at $208.89 on Thursday. The firm has a market capitalization of $72.07 billion, a PE ratio of 30.63, a P/E/G ratio of 4.51 and a beta of 0.23. The firm’s 50 day moving average price is $201.54. The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.04 and a current ratio of 1.05. CME Group Inc has a 52-week low of $161.05 and a 52-week high of $210.17.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, July 31st. The financial services provider reported $1.76 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.75 by $0.01. The firm had revenue of $1.27 billion during the quarter, compared to analysts’ expectations of $1.27 billion. CME Group had a net margin of 39.36% and a return on equity of 9.14%. The business’s revenue for the quarter was up 20.1% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.74 earnings per share. On average, analysts forecast that CME Group Inc will post 6.66 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 25th. Investors of record on Tuesday, September 10th will be issued a dividend of $0.75 per share. This represents a $3.00 dividend on an annualized basis and a yield of 1.44%. CME Group’s dividend payout ratio is currently 43.99%.

CME Group Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Featured Story: Why is the Consumer Price Index (CPI) important?

Want to see what other hedge funds are holding CME?Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for CME Group and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

Cornerstone Advisors Inc. Grows Holdings in CME Group Inc (NASDAQ:CME)

Cornerstone Advisors Inc. grew its holdings in CME Group Inc (NASDAQ:CME) by 5.9% in the 2nd quarter, according to the company in its most recent …

CME Group logoCornerstone Advisors Inc. grew its holdings in CME Group Inc (NASDAQ:CME) by 5.9% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 2,199 shares of the financial services provider’s stock after acquiring an additional 123 shares during the quarter. Cornerstone Advisors Inc.’s holdings in CME Group were worth $427,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also modified their holdings of CME. Dimensional Fund Advisors LP increased its holdings in shares of CME Group by 2.8% in the 4th quarter. Dimensional Fund Advisors LP now owns 906,174 shares of the financial services provider’s stock valued at $170,463,000 after acquiring an additional 24,717 shares during the last quarter. Geode Capital Management LLC grew its stake in CME Group by 12.9% during the fourth quarter. Geode Capital Management LLC now owns 4,715,269 shares of the financial services provider’s stock valued at $885,776,000 after acquiring an additional 537,917 shares in the last quarter. Actinver Wealth Management Inc. purchased a new position in CME Group during the fourth quarter valued at approximately $332,000. MUFG Securities EMEA plc grew its stake in CME Group by 5.1% during the fourth quarter. MUFG Securities EMEA plc now owns 9,700 shares of the financial services provider’s stock valued at $1,825,000 after acquiring an additional 467 shares in the last quarter. Finally, Dubuque Bank & Trust Co. grew its stake in CME Group by 83.1% during the first quarter. Dubuque Bank & Trust Co. now owns 152 shares of the financial services provider’s stock valued at $25,000 after acquiring an additional 69 shares in the last quarter. 84.58% of the stock is owned by institutional investors and hedge funds.

CME Group stock traded up $1.24 during mid-day trading on Thursday, hitting $210.13. 514,209 shares of the company traded hands, compared to its average volume of 1,310,953. CME Group Inc has a one year low of $161.05 and a one year high of $210.17. The firm has a market capitalization of $72.07 billion, a PE ratio of 30.81, a price-to-earnings-growth ratio of 4.51 and a beta of 0.23. The company has a current ratio of 1.05, a quick ratio of 1.04 and a debt-to-equity ratio of 0.15. The business’s fifty day moving average price is $201.54.

CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, July 31st. The financial services provider reported $1.76 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.75 by $0.01. The business had revenue of $1.27 billion during the quarter, compared to analyst estimates of $1.27 billion. CME Group had a net margin of 39.36% and a return on equity of 9.14%. CME Group’s revenue for the quarter was up 20.1% on a year-over-year basis. During the same period in the previous year, the business posted $1.74 earnings per share. As a group, sell-side analysts forecast that CME Group Inc will post 6.66 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 25th. Stockholders of record on Tuesday, September 10th will be issued a $0.75 dividend. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.43%. CME Group’s payout ratio is 43.99%.

In related news, CEO Terrence A. Duffy sold 35,000 shares of CME Group stock in a transaction on Thursday, August 1st. The shares were sold at an average price of $200.15, for a total value of $7,005,250.00. Following the transaction, the chief executive officer now directly owns 79,057 shares of the company’s stock, valued at $15,823,258.55. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Elizabeth A. Cook sold 300 shares of CME Group stock in a transaction on Monday, June 10th. The stock was sold at an average price of $204.27, for a total transaction of $61,281.00. Following the completion of the transaction, the director now directly owns 20,821 shares in the company, valued at $4,253,105.67. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 80,863 shares of company stock valued at $16,110,535. Company insiders own 1.20% of the company’s stock.

Several equities analysts recently commented on CME shares. Citigroup set a $202.00 price objective on shares of CME Group and gave the company a “buy” rating in a research note on Thursday, May 2nd. Wells Fargo & Co boosted their price objective on shares of CME Group from $176.00 to $200.00 and gave the company a “market perform” rating in a research note on Wednesday, July 3rd. Rosenblatt Securities cut shares of CME Group from a “neutral” rating to a “sell” rating in a research note on Thursday, April 18th. BidaskClub cut shares of CME Group from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, June 11th. Finally, Zacks Investment Research lowered shares of CME Group from a “hold” rating to a “sell” rating and set a $158.00 target price for the company. in a research report on Monday, May 27th. Three research analysts have rated the stock with a sell rating, five have issued a hold rating and eight have given a buy rating to the company. CME Group currently has a consensus rating of “Hold” and a consensus target price of $192.14.

CME Group Company Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Featured Article: What is Depreciation?

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for CME Group and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts